VYGR - Voyager Therapeutics Inc logo

VYGR

Voyager Therapeutics Inc

Voyager Therapeutics develops genetic therapies for neurological diseases, including VY1706 for Alzheimer's and treatments for Huntington's and ALS. It utilizes an AAV capsid discovery platform and partners with major pharmaceutical companies for broader applications.

⚕️ Healthcare NASDAQ Listed 2015 $ USD
$1,000 invested 10 years ago $200today

Score Overview

1 Year
Score
Net Growth10.02%
Net TrendGrew
Net Income Consistency
Rev Growth-14.65%
Rev TrendShrank
Revenue Consistency
5 Years
Score4.0
Net Growth-63.15%
Net Trend60%
Net Income Consistency
Rev Growth-7.90%
Rev Trend40%
Revenue Consistency
10 Years
Score
Net Growth-168.03%
Net Trend50%
Net Income Consistency
Rev Growth142.33%
Rev Trend40%
Revenue Consistency
All Time
Score
Net Growth-263.06%
Net Trend45%
Net Income Consistency
Rev Growth98.79%
Rev Trend36%
Revenue Consistency

See the full market ranking →

Voyager Therapeutics Inc fundamental performance

Between 2020 and 2025, revenue declined from $ 171M to $ 40M and net income went from $ 36M to -$ 119M. Revenue increased in 2 of those 5 years; net income in 3.

Between 2015 and 2025, revenue grew from $ 17M to $ 40M and net income went from -$ 29M to -$ 119M. Revenue increased in 4 of those 10 years; net income in 5.

Voyager Therapeutics Inc currently holds a 5-year HDB Score of 4.0 out of 10. How the HDB Score is calculated.

Net Income x Stock Price

Historical Returns

Historical Returns
PeriodPriceReturn
Last Price2026-08-12
$ 3.20
1 Year2025-08-12
$ 3.39-5.60%
5 Years2021-08-12
$ 2.968.11%
10 Years2016-08-12
$ 15.98-79.97%
All Time2015-11-11
$ 17.75-81.97%

Prices are split & dividend adjusted. All values are reported in USD.

Fundamental Data

Year
2026$ 34M-$ 107M$ 116M
2025$ 40M-$ 119M$ 196M
2024$ 80M-$ 65M$ 266M
2023$ 250M$ 132M$ 230M
2022$ 40M-$ 46M$ 118M
2021$ 37M-$ 66M$ 132M
2020$ 171M$ 36M$ 181M
2019$ 104M-$ 40M$ 281M
2018$ 7M-$ 88M$ 155M
2017$ 10M-$ 70M$ 169M
2016$ 14M-$ 40M$ 174M
IPO2015$ 17M-$ 29M$ 224M

Explore beyond VYGR

You're looking at Voyager Therapeutics Inc. Members apply the same fundamental framework across all 3,860 companies we cover.

$99/year $149 founding price

Unlock Holder Dashboard

30-day money-back guarantee.

Explore other companies